BACKGROUND: Folate intake has been associated with reduced colorectal cancer risk; however, few studies have prospectively examined circulating folate or other related one-carbon biomarkers. METHODS: We conducted a nested case-control study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort of 50- to 69-year-old Finnish men to investigate associations between serum folate, vitamin B6, vitamin B12, riboflavin, and homocysteine and risk of colon and rectal cancers. Controls were alive and cancer-free at the time of case diagnosis and matched 1:1 on age and date of baseline fasting serum collection with cases (152 colon and 126 rectal cancers). Multivariate-adjusted odds ratios and 95% confidence intervals were calculated using conditional logistic regression. RESULTS:Serum vitamin B6 was inversely associated with colon cancer [odds ratio, 0.30 (95% confidence interval, 0.11-0.82) in the highest versus lowest quintile]. An increased risk of colon cancer was suggested for men in the middle quintile of serum folate, but without indication of a dose-response relationship. None of the other serum biomarkers were associated with colon or rectal cancer, and we observed no interactions with alcohol consumption or methionine or protein intake. A priori combinations of the five one-carbon serum biomarkers provided no clear evidence to support a collective influence on colorectal cancer risk. CONCLUSIONS: Our results support the hypothesis that higher vitamin B6 status may play a role in inhibiting colon cancer carcinogenesis; however, folate and other one-carbon related biomarkers were not associated with colon or rectal cancer.
RCT Entities:
BACKGROUND:Folate intake has been associated with reduced colorectal cancer risk; however, few studies have prospectively examined circulating folate or other related one-carbon biomarkers. METHODS: We conducted a nested case-control study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort of 50- to 69-year-old Finnish men to investigate associations between serum folate, vitamin B6, vitamin B12, riboflavin, and homocysteine and risk of colon and rectal cancers. Controls were alive and cancer-free at the time of case diagnosis and matched 1:1 on age and date of baseline fasting serum collection with cases (152 colon and 126 rectal cancers). Multivariate-adjusted odds ratios and 95% confidence intervals were calculated using conditional logistic regression. RESULTS: Serum vitamin B6 was inversely associated with colon cancer [odds ratio, 0.30 (95% confidence interval, 0.11-0.82) in the highest versus lowest quintile]. An increased risk of colon cancer was suggested for men in the middle quintile of serum folate, but without indication of a dose-response relationship. None of the other serum biomarkers were associated with colon or rectal cancer, and we observed no interactions with alcohol consumption or methionine or protein intake. A priori combinations of the five one-carbon serum biomarkers provided no clear evidence to support a collective influence on colorectal cancer risk. CONCLUSIONS: Our results support the hypothesis that higher vitamin B6 status may play a role in inhibiting colon cancer carcinogenesis; however, folate and other one-carbon related biomarkers were not associated with colon or rectal cancer.
Authors: Paul F Jacques; Renee Kalmbach; Pamela J Bagley; Giuseppina T Russo; Gail Rogers; Peter W F Wilson; Irwin H Rosenberg; Jacob Selhub Journal: J Nutr Date: 2002-02 Impact factor: 4.798
Authors: J Ma; M J Stampfer; B Christensen; E Giovannucci; D J Hunter; J Chen; W C Willett; J Selhub; C H Hennekens; R Gravel; R Rozen Journal: Cancer Epidemiol Biomarkers Prev Date: 1999-09 Impact factor: 4.254
Authors: T R Fears; R G Ziegler; J L Donaldson; R T Falk; R N Hoover; F Z Stanczyk; J B Vaught; M H Gail Journal: Cancer Epidemiol Biomarkers Prev Date: 2000-04 Impact factor: 4.254
Authors: Lisa Harnack; David R Jacobs; Kristin Nicodemus; DeAnn Lazovich; Kristin Anderson; Aaron R Folsom Journal: Nutr Cancer Date: 2002 Impact factor: 2.900
Authors: Andrew Flood; Laura Caprario; Nilanjan Chaterjee; James V Lacey; Catherine Schairer; Arthur Schatzkin Journal: Cancer Causes Control Date: 2002-08 Impact factor: 2.506
Authors: Aurelie Chanson; Laurence D Parnell; Eric D Ciappio; Zhenhua Liu; Jimmy W Crott; Katherine L Tucker; Joel B Mason Journal: Am J Clin Nutr Date: 2009-04-29 Impact factor: 7.045
Authors: Elizabeth L Cope; Martha J Shrubsole; Sarah S Cohen; Qiuyin Cai; Jie Wu; Per Magne Ueland; Øivind Midttun; Jennifer S Sonderman; William J Blot; Lisa B Signorello Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-08-15 Impact factor: 4.254
Authors: Marian L Neuhouser; Ting-Yuan David Cheng; Shirley A A Beresford; Elissa Brown; Xiaoling Song; Joshua W Miller; Yingye Zheng; Cynthia A Thomson; James M Shikany; Mara Z Vitolins; Thomas Rohan; Ralph Green; Cornelia M Ulrich Journal: Int J Cancer Date: 2015-02-24 Impact factor: 7.396
Authors: Loïc Le Marchand; Kami K White; Abraham M Y Nomura; Lynne R Wilkens; Jacob S Selhub; Maarit Tiirikainen; Marc T Goodman; Suzanne P Murphy; Brian E Henderson; Laurence N Kolonel Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-08 Impact factor: 4.254
Authors: Jung Eun Lee; Esther K Wei; Charles S Fuchs; David J Hunter; I-Min Lee; Jacob Selhub; Meir J Stampfer; Walter C Willett; Jing Ma; Edward Giovannucci Journal: Cancer Causes Control Date: 2012-02-26 Impact factor: 2.506
Authors: James J Goedert; Joshua N Sampson; Steven C Moore; Qian Xiao; Xiaoqin Xiong; Richard B Hayes; Jiyoung Ahn; Jianxin Shi; Rashmi Sinha Journal: Carcinogenesis Date: 2014-07-18 Impact factor: 4.944
Authors: Yeong Sook Yoon; Seungyoun Jung; Xuehong Zhang; Shuji Ogino; Edward L Giovannucci; Eunyoung Cho Journal: Int J Cancer Date: 2016-09-01 Impact factor: 7.396
Authors: Joshua W Miller; Shirley A A Beresford; Marian L Neuhouser; Ting-Yuan David Cheng; Xiaoling Song; Elissa C Brown; Yingye Zheng; Beatriz Rodriguez; Ralph Green; Cornelia M Ulrich Journal: Am J Clin Nutr Date: 2013-02-20 Impact factor: 7.045